BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Avexa Limited 



Victoria      Australia
Phone: 61-3-9208-4000 Fax: 61-3-9208-4356


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
PharmaVentures Ltd Engaged by Avexa Limited (AVX:AU) to Assist in the Out-licensing of Apricitabine 7/12/2011 10:36:14 AM
Avexa Limited (AVX:AU) Plunges 75% After Scrapping Most Advanced Drug; Company Announces CEO Resignation, Headcount Reduction and Plan to Explore Strategic Alternatives 5/10/2010 11:41:53 AM
Avexa Limited (AVX.AX) Closes ATC’s Phase III Trial to Evaluate Data 10/2/2009 8:32:58 AM
CSIRO Invests A $2 Million in Avexa Limited (AVX.AX)'s HCV Program 7/15/2009 6:54:09 AM
Avexa Limited (AVX.AX) Announces Changes to Its Board of Directors 7/1/2009 8:49:37 AM
Positive Outcome Reached at 16 Weeks for Avexa Limited (AVX.AX)'s ATC Phase III Trial 6/4/2009 10:17:58 AM
Avexa Limited (AVX.AX) Raises $17M Following Closure of 2009 Rights Issue 4/30/2009 9:15:47 AM
Avexa Limited (AVX.AX) Nominates Proven Pharmaceuticals Executive to Its Board of Directors 4/22/2009 8:47:50 AM
Avexa Limited (AVX.AX) Reaches First Critical Evaluation Point for ATC's Phase III Trial 3/25/2009 9:20:47 AM
Avexa Limited (AVX.AX) Reports Positive 96 Week Data for HIV Drug Apricitabine (ATC) 3/16/2009 7:21:51 AM
12345